Retension Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Retension Pharmaceuticals's estimated annual revenue is currently $1.4M per year.
- Retension Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Retension Pharmaceuticals has 9 Employees.
- Retension Pharmaceuticals grew their employee count by 50% last year.
Retension Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Founder & Chairman | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Operations Officer | Reveal Email/Phone |
4 | Head Clinical Operations | Reveal Email/Phone |
5 | SVP, Development | Reveal Email/Phone |
6 | Director & Audit Committee Chair | Reveal Email/Phone |
7 | Head, Clinical Operations | Reveal Email/Phone |
Retension Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Retension Pharmaceuticals?
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these studies, RTN-001 was well tolerated and demonstrated a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension. RTN-001 is a second generation PDE5i that preferentially distributes to cardiovascular tissues, where it acts to mediate a sustained and clinically significant impact on central and brachial blood pressure in patients with uncontrolled hypertension.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 9 | 50% | N/A |
#2 | $0.7M | 9 | N/A | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.7M | 9 | N/A | N/A |